CD8A and neoplasm: However, profiling of one patient’s peripheral blood revealed a significant increase in CD8+ T cells specific to the tumor-specific antigen MAGE-A3 during treatment, which continued to increase 2 months after treatment [16], suggesting the possibility of local or mild immune memory.